Recruiting Evaluation of the Role of miR-1 in the Pathogenesis and as a Biomarker in Muscular Dystrophies and Congenital Myopathies NCT07415837 Conditions Congenital Myopathies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne / Becker Muscular Dystrophy, +16 more Locations CHU de Clermont-Ferrand — Clermont-Ferrand, France View Trial Details
Recruiting Myotonic Dystrophy Family Registry NCT02398786 Conditions Congenital Myotonic Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dystrophia Myotonica, +24 more Locations Myotonic Dystrophy Foundation — Oakland, California, United States View Trial Details
Completed Methylphenidate in Myotonic Dystrophy Type 1 NCT01421992 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disorders of Excessive Somnolence, Dyssomnias, +15 more Locations Institute of Readaptation in Physical Deficiency — Québec, Quebec, Canada View Trial Details
